Toggle menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Nightmare of Eden (TV story)

From Tardis Wiki, the free Doctor Who reference
Revision as of 06:09, 16 July 2007 by 75.84.234.0 (talk) (→‎Crew)


Synopsis

The TARDIS arrives on the space liner Empress which has become locked together with a private ship, the Hecate, after colliding with it on emerging from hyperspace.

The Doctor and Romana meet the scientist Tryst, who has with him a Continuous Event Transmuter (CET) machine containing crystals on which are stored supposed recordings of planets that he and his team have visited.

Someone on board the liner is smuggling the dangerously addictive drug vraxoin, and to complicate matters the interface between the two ships allows some monstrous Mandrels from the mud-swamps of Eden to escape from the CET machine - which does not merely take recordings but actually displaces whole planetary areas into its crystals.

The smugglers are revealed to be Tryst and the Hecate's pilot, Dymond. Vraxoin is in fact the material into which the Mandrels decompose when they are killed. The Doctor thwarts this plan, separates the two ships and returns the Mandrels to Eden.

Plot

to be added

Cast

Crew

  • Director - Graham Williams (Graham Williams decided to dispense with Alan Bromly's services toward the end of the story's second studio session and directed the remainder himself, without on-screen credit.)

References

Story Notes

  • Vraxoin was originally called 'xylophilin', but was changed so as not to sound appealing to children.
  • Working title: Nightmare of Evil.

Ratings

  • Part 1 - 8.7 million viewers
  • Part 2 - 9.6 million viewers
  • Part 3 - 9.6 million viewers
  • Part 4 - 9.4 million viewers

Myths

to be added

Location Filming

to be added

Discontinuity, Plot Holes, Errors

to be added

Continuity

to be added

Target Novelisations

to be added

See Also

DVD and Video Releases

to be added

External Links

Cookies help us deliver our services. By using our services, you agree to our use of cookies.